Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
CRO
Sort By
Newest First
1 / 12
Particle Analysis
Advancing Subvisible Particle Characterization with Artificial Intelligence
Daniel Weinbuch, Ph.D.
Coriolis Pharma
PAO-03-25-CL-02
Mar 11, 2025
Manufacturing
Advanced Pharmaceutical Manufacturing Concepts Are Quickly Becoming Realities
Tonia Becker; RECONNEX 365
Nice Insight
PAO-02-25-CL-05
Feb 10, 2025
Future Medicines
How Today’s Pharmaceutical Industry is Transforming to Support the Medicines of the Future
Tonia Becker; RECONNEX 365
Nice Insight
PAO-02-25-CL-04
Feb 06, 2025
Developability
Streamlining Drug Development with Integrated In Silico and Laboratory Developability Assessments
Andrea Arsiccio, Ph.D.,; Eva Keilhauer, Ph.D.; Kristian Le Vay, Ph.D.
Coriolis Pharma
PAO-01-25-CL-12
Jan 27, 2025
Large Molecule
Managing Pharmacovigilance Challenges for Biosimilars
Ivana Lisec, MPharm
PrimeVigilance
PAO-11-24-CL-05
Jan 02, 2025
CRO
Lindus Health Rolls Out "All-in-One Infectious Disease CRO" Bespoke to Clinical Trials for Infectious Disease Interventions
Lindus Health
PR-11-24-NI-113
Nov 19, 2024
Particle ID
Leveraging Formulation Development Experience for Effective Particle Identification
Jörg Müller, Ph.D.
Coriolis Pharma
PAO-10-24-CL-10
Nov 18, 2024
Precision Medicine
Advancing Personalized Medicines and Precision Therapeutics
Thermo Fisher Scientific
PAO-11-24-RTM-10
Nov 15, 2024
Bioassays
State-of-the-Art, Multi-Modality Bioanalysis in Brisbane
Resolian
PAO-11-24-RTM-04
Nov 12, 2024
Clinical Trials
ProPharma Group is Supporting Better Clinical Outcomes Down Under
ProPharma
PAO-10-24-RTM-05
Nov 04, 2024
Clinical Trials
Passion and Understanding Essential for Rare Disease Clinical Trials
Juliet Moritz
Ergomed
PAO-10-24-CL-03
Oct 29, 2024
Oncology Trials
Navigating the Complex Landscape of Oncology Trials
Colin Hayward, MB BS
Ergomed
PAO-10-24-CL-04
Oct 22, 2024
Appointment
Bio X Cell Announces Board of Director Appointments
Bio X Cell
PR-10-24-NI-45
Oct 17, 2024
Commercialization
Development Strategies for Overcoming Commercialization Challenges
Matthias Lucke, Ph.D.
Coriolis Pharma
PAO-09-24-CL-10
Sep 17, 2024
Ophthalmology
The Shift from Early- to Late-Phase Ophthalmology Retina Market in 2024: Proactive Planning for Late-Stage Clinical Success
Tracey Roberts, MSHS; Jennifer Christiansen, Ph.D.; Debra Schaumberg, Sc.D., O.D., M.P.H.
PPD, part of Thermo Fisher Scientific
PAO-08-24-CL-05
Sep 16, 2024
IND Enablement
IND Enablement and Drug Product Development – Mitigating Risk and Accelerating through the "Valley of Death"
Johannes Clemens
Coriolis Pharma
PAO-08-24-CL-07
Aug 16, 2024
Changing Roles
How are Advancements in Technology Reshaping the Roles and Capabilities of CDMOs and CROs in the Drug Development Life Cycle?
Pharma's Almanac
PAO-08-24-RT-01
Aug 07, 2024
Global Access
How Can (Bio)pharmaceutical Companies Contribute to Improving Global Access to Essential Medications?
Pharma's Almanac
PAO-08-24-RT-02
Aug 07, 2024
Developability
Streamlining the Path to Approval with Developability and Pre-Formulation Platforms
Andrea Hawe
Coriolis Pharma
PAO-07-24-CL-11
Aug 01, 2024
CDMO Model
Rethinking the Conventional CDMO Model
Wheeler Bio
PAO-08-24-CL-04
Jul 29, 2024
1 / 12
